Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATH008 Cream for Capecitabine-Induced PPES
NCT01316406Phase 2Completed
- Sponsor
- AdvanCell
- Start
- Feb 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of allopurinol in palmar-plantar erythrodysesthesia (PPE), sponsored by AdvanCell. Started Feb 2011; status: completed.
02
Drugs
allopurinol
03
Conditions
palmar-plantar erythrodysesthesia (PPE)
Beyond the preview
Go deeper on NCT01316406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316406.